Form 8-K - Current report:
SEC Accession No. 0001640334-21-001125
Filing Date
2021-05-12
Accepted
2021-05-12 14:21:20
Documents
4
Period of Report
2021-05-06
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K lxrp_10q.htm 8-K 17391
2 PRESS RELEASE DATED MAY 6, 2021 lxrp_ex991.htm EX-99.1 25263
3 PRESS RELEASE DATED MAY 7, 2021 lxrp_ex992.htm EX-99.2 7657
4 PRESS RELEASE DATED MAY 12, 2021 lxrp_ex993.htm EX-99.3 10586
  Complete submission text file 0001640334-21-001125.txt   62153
Mailing Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7
Business Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7 250-765-6424
Lexaria Bioscience Corp. (Filer) CIK: 0001348362 (see all company filings)

EIN.: 202000871 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 8-K | Act: 34 | File No.: 001-39874 | Film No.: 21914677
SIC: 2834 Pharmaceutical Preparations